PMID- 12887239 OWN - NLM STAT- MEDLINE DCOM- 20031112 LR - 20191210 IS - 0899-823X (Print) IS - 0899-823X (Linking) VI - 24 IP - 7 DP - 2003 Jul TI - Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. PG - 506-13 AB - OBJECTIVES: To evaluate the long-term efficacy of urinary Foley catheters (latex and silicone) impregnated with (1) chlorhexidine and silver sulfadiazine (CXS) and (2) chlorhexidine, silver sulfadiazine, and triclosan (CXST) in inhibiting extra-luminal bacterial adherence and to compare their efficacy with that of silver hydrogel latex (SH) and nitrofurazone-treated silicone (NF) catheters. DESIGN: The antimicrobial spectrum of these catheters was evaluated using a zone of inhibition assay. A novel in vitro urinary tract model was developed to study the potential in vivo efficacy of antimicrobial catheters in preventing extraluminal bacterial colonization. The "meatus" was inoculated daily with Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Enterococcus faecalis, Pseudomonas aerginosa, and Candida albicans. The "bladder" portion of the model was cultured daily to determine bacterial growth. RESULTS: Both CXS and CXST catheters had a broader antimicrobial spectrum than SH and NF catheters. In the in vitro model, CXST latex and silicone catheters exhibited significantly better efficacy (3 to 25days) against uropathogens, compared with CXS (1 to 14 days) and control (0 to 5 days) catheters (P = .01). CXST latex catheters exhibited significantly longer protection against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa, compared with SH catheters (P = .01). CXST silicone catheters resisted colonization with Staphylococcus aureus and Staphylococcus epidermidis for a significantly longer period (23 to 24 days) than did NF catheters (9 to 11 days) (P = .01). CONCLUSION: Catheters impregnated with synergistic combinations of chlorhexidine, silver sulfadiazine, and triclosan exhibited broad-spectrum, long-term resistance against microbial colonization on their outer surfaces. FAU - Gaonkar, Trupti A AU - Gaonkar TA AD - Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. FAU - Sampath, Lester A AU - Sampath LA FAU - Modak, Shanta M AU - Modak SM LA - eng PT - Evaluation Study PT - Journal Article PL - United States TA - Infect Control Hosp Epidemiol JT - Infection control and hospital epidemiology JID - 8804099 RN - 0 (Anti-Infective Agents, Urinary) RN - 4NM5039Y5X (Triclosan) RN - R4KO0DY52L (Chlorhexidine) RN - W46JY43EJR (Silver Sulfadiazine) SB - IM MH - Anti-Infective Agents, Urinary/*administration & dosage/classification MH - Bacteria/drug effects MH - Catheters, Indwelling MH - Chlorhexidine/administration & dosage/pharmacology MH - Colony Count, Microbial MH - *Drug Delivery Systems MH - Humans MH - In Vitro Techniques MH - Models, Biological MH - Silver Sulfadiazine/administration & dosage/pharmacology MH - Treatment Outcome MH - Triclosan/administration & dosage/pharmacology MH - United States MH - Urinary Catheterization/*instrumentation EDAT- 2003/07/31 05:00 MHDA- 2003/11/13 05:00 CRDT- 2003/07/31 05:00 PHST- 2003/07/31 05:00 [pubmed] PHST- 2003/11/13 05:00 [medline] PHST- 2003/07/31 05:00 [entrez] AID - ICHE5720 [pii] AID - 10.1086/502241 [doi] PST - ppublish SO - Infect Control Hosp Epidemiol. 2003 Jul;24(7):506-13. doi: 10.1086/502241.